geraniol has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elson, CE; Hildebrandt, LA; Yu, SG | 1 |
| Elson, CE; Jung, M; Mo, H; Tatman, D | 1 |
| Elson, CE; Grummer, M; Shoff, SM; Yatvin, MB | 1 |
3 other study(ies) available for geraniol and B16 Melanoma
| Article | Year |
|---|---|
Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice.
Topics: Acyclic Monoterpenes; Animals; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms, Experimental; Male; Melanoma, Experimental; Mevalonic Acid; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Rats; Rats, Inbred BUF; Skin Neoplasms; Terpenes; Tumor Cells, Cultured | 1995 |
Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas.
Topics: Acyclic Monoterpenes; Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cholesterol; Dose-Response Relationship, Drug; Farnesol; Melanoma, Experimental; Mice; ortho-Aminobenzoates; Terpenes; Tumor Cells, Cultured | 2000 |
Concentration-dependent increase of murine P388 and B16 population doubling time by the acyclic monoterpene geraniol.
Topics: Acyclic Monoterpenes; Animals; Cell Division; Growth Inhibitors; Leukemia, Experimental; Melanoma, Experimental; Mevalonic Acid; Mice; Survival Analysis; Terpenes; Tumor Cells, Cultured | 1991 |